- Our World
- Our Business
- Life at Lupin
- Global Sites
The Australian pharmaceutical market is valued at USD 13 billion. Generics constitute more than 30% of the pharmaceutical sales volume in the region. The Company’s Australian subsidiary, Generic Health generated revenues of AUD 34 million (Rs.1,713 million) and reported a growth of 17%. This performance helped the Company surpass market growth rate significantly. Generic Health is a supplier of generic Rx and OTC to pharmacies in Australia.
It is the 7th largest company and also 4th fastest growing company in the generic segment in the country.